The infant and toddler with diabetes: Challenges of diagnosis and management

D Daneman1, M Frank, K Perlman

  • 1Division of Endocrinology.

Insights

Type 1 diabetes in infants and toddlers presents unique diagnostic and management challenges. Achieving a blood glucose target of 6-12 mmol/L balances control with risks in very young children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 diabetes is increasingly diagnosed in younger children, posing unique challenges.
  • Infants and toddlers with type 1 diabetes often lack classical symptoms at diagnosis.
  • Early diagnosis requires heightened clinical suspicion from healthcare professionals.

Purpose of the Study:

  • To outline the challenges in diagnosing and managing type 1 diabetes in infants and toddlers.
  • To discuss therapeutic strategies balancing metabolic control and risks in very young children.
  • To highlight the psychosocial impact and management needs for families.

Main Methods:

  • Review of epidemiological trends in pediatric type 1 diabetes.
  • Analysis of diagnostic difficulties in non-classical presentations.
  • Evaluation of treatment regimens for infants and toddlers with type 1 diabetes.

Main Results:

  • Younger children may not exhibit typical diabetes symptoms, risking delayed diagnosis.
  • Tight glycemic control in very young children can lead to severe hypoglycemia and potential cognitive impairment.
  • A blood glucose target range of 6 to 12 mmol/L is suggested for managing type 1 diabetes in this age group.

Conclusions:

  • Managing type 1 diabetes in infants and toddlers requires a tailored approach.
  • Successful outcomes depend on family education, experienced healthcare teams, and community support.
  • Balancing metabolic control with the child's developmental stage is crucial to prevent complications.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...